Compile Data Set for Download or QSAR
maximum 50k data
Found 47 Enz. Inhib. hit(s) with all data for entry = 50033307
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343131(2-(2-cyanopyrimidin-5-yl)-N-(3-ethylphenyl)-4-o-to...)
Affinity DataIC50:  1nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343129(2-(4-cyanopyridin-3-yl)-N-(3-ethylphenyl)-4-o-toly...)
Affinity DataIC50:  3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343132(2-(3,5-dimethylisoxazol-4-yl)-N-(3-ethylphenyl)-4-...)
Affinity DataIC50:  4nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343120(4-(2,6-dimethylphenyl)-N-(3-ethylphenyl)-2-(pyridi...)
Affinity DataIC50:  9nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343128(2-(benzo[d][1,3]dioxol-5-yl)-N-(3-ethylphenyl)-4-o...)
Affinity DataIC50:  10nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343130(CHEMBL1771458 | N-(3-ethylphenyl)-2-(pyrimidin-5-y...)
Affinity DataIC50:  12nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343127(CHEMBL1771455 | N-(3-ethylphenyl)-2-(quinolin-3-yl...)
Affinity DataIC50:  13nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343094(2-(4-cyanophenyl)-N-(3-ethylphenyl)-4-o-tolyl-7,8-...)
Affinity DataIC50:  16nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343095(CHEMBL1771452 | N-(3-ethylphenyl)-2-(4-fluoropheny...)
Affinity DataIC50:  25nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343109(CHEMBL1771244 | N-(3-(1-fluoroethyl)phenyl)-2-(pyr...)
Affinity DataIC50:  29nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343125(CHEMBL1771453 | N-(3-ethylphenyl)-2-(3-fluoropheny...)
Affinity DataIC50:  30nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343121(4-(2-chloro-6-methylphenyl)-N-(3-ethylphenyl)-2-(p...)
Affinity DataIC50:  50nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343122(4-(2,6-dichlorophenyl)-N-(3-ethylphenyl)-2-(pyridi...)
Affinity DataIC50:  51nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343090(CHEMBL1771446 | N-(3-ethylphenyl)-4-o-tolyl-2-p-to...)
Affinity DataIC50:  62nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343103(CHEMBL1771238 | N-(3-ethylphenyl)-2-(pyridin-3-yl)...)
Affinity DataIC50:  81nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343089(CHEMBL1771445 | N-(3-ethylphenyl)-2-phenyl-4-o-tol...)
Affinity DataIC50:  87nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343093(2-(3-cyanophenyl)-N-(3-ethylphenyl)-4-o-tolyl-7,8-...)
Affinity DataIC50:  140nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343104(CHEMBL1771239 | N-(3-propylphenyl)-2-(pyridin-3-yl...)
Affinity DataIC50:  150nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343111(CHEMBL1771246 | N-(3-chloro-5-ethylphenyl)-2-(pyri...)
Affinity DataIC50:  160nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343116(4-(2-ethylphenyl)-N-(3-ethylphenyl)-2-(pyridin-3-y...)
Affinity DataIC50:  390nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343100(CHEMBL1771235 | N-(3-ethoxyphenyl)-2-(pyridin-3-yl...)
Affinity DataIC50:  420nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343112(4-(2-chlorophenyl)-N-(3-ethylphenyl)-2-(pyridin-3-...)
Affinity DataIC50:  440nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343097(CHEMBL1771232 | N-(3-chlorophenyl)-2-(pyridin-3-yl...)
Affinity DataIC50:  580nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343110(CHEMBL1771245 | N-(3-(1,1-difluoroethyl)phenyl)-2-...)
Affinity DataIC50:  620nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343101(CHEMBL1771236 | N-(3-(methylthio)phenyl)-2-(pyridi...)
Affinity DataIC50:  630nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343126(CHEMBL1771454 | N-(3-ethylphenyl)-2-(naphthalen-2-...)
Affinity DataIC50:  880nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343119(CHEMBL1771438 | N-(3-ethylphenyl)-4-(2-(hydroxymet...)
Affinity DataIC50:  1.10E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343105(2-(pyridin-3-yl)-4-o-tolyl-N-(3-vinylphenyl)-7,8-d...)
Affinity DataIC50:  1.20E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343106(CHEMBL1771241 | N-(3-cyclopropylphenyl)-2-(pyridin...)
Affinity DataIC50:  1.20E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343091(CHEMBL1771447 | N-(3-ethylphenyl)-2-m-tolyl-4-o-to...)
Affinity DataIC50:  1.30E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343124(CHEMBL1771444 | N-(3-ethylphenyl)-2-(pyridin-4-yl)...)
Affinity DataIC50:  1.40E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343102(2-(pyridin-3-yl)-N-m-tolyl-4-o-tolyl-7,8-dihydropy...)
Affinity DataIC50:  1.90E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343123(3-(6-(3-ethylphenylcarbamoyl)-4-o-tolyl-5,6,7,8-te...)
Affinity DataIC50:  2.80E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343117(CHEMBL1771436 | N-(3-ethylphenyl)-4-(2-methoxyphen...)
Affinity DataIC50:  3.30E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343113(CHEMBL1771248 | N-(3-ethylphenyl)-4-(2-fluoropheny...)
Affinity DataIC50:  3.70E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343096(CHEMBL1771230 | N-phenyl-2-(pyridin-3-yl)-4-o-toly...)
Affinity DataIC50:  4.90E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343130(CHEMBL1771458 | N-(3-ethylphenyl)-2-(pyrimidin-5-y...)
Affinity DataIC50: >5.00E+3nMAssay Description:Displacement of [35S]MK-0499 from human ERGMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343132(2-(3,5-dimethylisoxazol-4-yl)-N-(3-ethylphenyl)-4-...)
Affinity DataIC50: >5.00E+3nMAssay Description:Displacement of [35S]MK-0499 from human ERGMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343128(2-(benzo[d][1,3]dioxol-5-yl)-N-(3-ethylphenyl)-4-o...)
Affinity DataIC50: >5.00E+3nMAssay Description:Displacement of [35S]MK-0499 from human ERGMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343099(CHEMBL1771234 | N-(3-methoxyphenyl)-2-(pyridin-3-y...)
Affinity DataIC50:  5.10E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343098(CHEMBL1771233 | N-(4-chlorophenyl)-2-(pyridin-3-yl...)
Affinity DataIC50:  5.80E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343107(CHEMBL1771242 | N-(3-acetylphenyl)-2-(pyridin-3-yl...)
Affinity DataIC50:  6.50E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343118(CHEMBL1771437 | N-(3-ethylphenyl)-4-(2-hydroxyphen...)
Affinity DataIC50:  6.50E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343115(4-(4-chloro-2-methylphenyl)-N-(3-ethylphenyl)-2-(p...)
Affinity DataIC50:  7.00E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343092(CHEMBL1771449 | N-(3-ethylphenyl)-4-o-tolyl-2-(4-(...)
Affinity DataIC50:  7.50E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343108(CHEMBL1771243 | N-(3-(1-hydroxyethyl)phenyl)-2-(py...)
Affinity DataIC50:  8.20E+3nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 14(Mus musculus)
Merck Frosst Center For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50343114(4-(3-chlorophenyl)-N-(3-ethylphenyl)-2-(pyridin-3-...)
Affinity DataIC50:  1.20E+4nMAssay Description:Antagonist activity at mouse P2Y14 expressed in human HEK cells coexpressing Galphai5 assessed as inhibition of UDP-glucose stimulated calcium releas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed